Yale University School of Medicine Psychiatry Associate ProfessorAppointed: 1999 Yale University School of Medicine Obstetrics, Gynecology and Reproductive Sciences Associate ProfessorAppointed: 2005 Yale University School of Epidemiology and Public Health Chronic Diseases InstructorAppointed: 2000 |  |
QualificationsResidency, McLean Hospital/Harvard Medical School, Psychiatry, 1990. M.D., Columbia University, Medicine, 1986. B.A., Amherst College, Political Science, Women's Studies, 1979. Expertise and Research InterestsThrough research, I am committed to servicing women who suffer from mood and anxiety disorders. My specific interests have included sex differences in these conditions as well as the relationship and treatment of mood and anxiety disorder occurring during the premenstrual phase of the menstrual cycle and during pregnancy and parturition. My research foci are several and include determining the efficacy and effectiveness of pharmacological treatments of perinatal mood disorders and PMDD, determine the degree of health care utilization among women with PMDD and perinatal depression and investigating the impact of perinatal depressive, anxiety and substance use disorders on birth outcomes. Other ExpertiseI have expertise in the administration of structured short term psychotherapies including interpersonal psychotherapy, cognitive behavioral therapy and motivational interviewing. I also have expertise in consult liason psychiatry.
Fellowship, McLean Hospital/Harvard Medical School, Neurosciences, 1992 Future ResearchI hope information gathered on mood disorders in women will influence and guide clinicians in determining the optimal interventions for their female patients. I also hope that the information gathered can be helpful to educate consumers about mood disorders such as depression during pregnancy, postpartum depression and severe premenstrual syndrome so that they can partner with their clinicians and obtain the best possible health care. Industrial RelevanceI collaborate with other researchers, community clinics, and the hospitals in the greater New Haven and Fairfield Counties, in an effort to increase understanding of women's psychiatric health issues. The goal is to contribute to both the scientific and local communities by conducting research that has clear, pratical applications for women. KeywordsCOS Keywords:Affective Disorders, Anxiety Disorders, Chronic Illness, Depression, Obstetrics or Gynecology, Pregnancy, Premenstrual Syndrome (PMS), Psychiatry, Women's Health, Women's Mental Health.Additional Terms:Anxiety Disorders, Major Depressive Disorder, Panic Disorder, Perinatal, Postpartum Depression (PPD), Postpartum Mood Disorders, Premenstrual Dysphoric Disorder (PMDD), Premenstrual Syndrome (PMS), Substance Use Disorders, Women's Health.Languages(Reading, Writing, Speaking)Spanish: (Functional, Basic, Functional) MembershipsAmerican Board of Psychiatry and Neurology American Medical Women's Association American Psychiatric Association North American Society for Psychosocial Obstetrics and Gynecology Society of Biological Psychiatry Surgeon General's Workshop on Women's Mental Health Honors and Awards2001-2005,
Best Doctors in New York Metro Area (selected annually)
2001-2005,
Best Doctors in U.S (selected annually)
1999-1999,
Psychiatric Research Award,
Texas Psychiatric Society
1996-1998,
Dallas Best Doctors (selected annually),
Previous Positions1998-1999, Associate Professor,
University of Texas Southwestern Medical Center at Dallas,
Medical School - Departments and Divisions,
Psychiatry
1992-1998, Assistant Professor,
University of Texas Southwestern Medical Center at Dallas,
Medical School - Departments and Divisions,
Psychiatry
1992-1998, Assistant Professor,
University of Texas Southwestern Medical Center at Dallas,
Ob & Gyn
1990-1992, Instructor,
Harvard University,
Medical School,
Psychiatry
1990-1992, Assistant Clinical Psychiatrist,
Brigham and Women's Hospital,
Psychiatry
Funding Received- United States Department of Health and Human Services (DHHS):
Screening for Depression During Pregnancy,
$670,000,
Jun 1, 2001
to May 30, 2005.
- National Institutes of Health (NIH):
Treating PMS/PMDD: Clinical Research vs Reality,
$460,000,
Aug 1, 2001
to 2005.
- National Institute of Drug Abuse:
Anxiety, Disinhibition, and Risk for Drug Abuse,
$874,184,
9/99
to 2005.
- National Institutes of Health (NIH):
Detection and Treatment of Postpartum Depression,
$700,000,
9/1999
to 8/2004.
- National Institutes of Health (NIH):
Symptom-Onset Antidepressant Treatment for PMDD,
2007
to 2012.
- Lilly Pharmaceuticals:
A Comparison Antidepressant Treatment in Women with and Without Postpartum Onset of Major Depressive Disorder,
2007
to 2008.
- National Institute of Child Health and Human Development:
Effects of Perinatal Depression on Preterm Delivery and Low Brith WeightLBW,
$5,676,655,
2004
to 2009.
- National Institute of Drug Abuse:
Psychosocial Research to Improve Drug Treatment in Pregnancy,
$2,429,288,
2004
to 2009.
Publications- Spoozak L, Gotman N, Smith MV, Belanger K, Yonkers KA (Sep 2008) Evaluation of a social support measure that may indicate risk of depression during pregnancy., Journal of affective disorders
 - Wallenstein GV, Blaisdell-Gross B, Gajria K, Guo A, Hagan M, Kornstein SG, Yonkers KA (Apr 2008) Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool., Journal of women's health (2002), 17 (3), 439-50
 - Yonkers KA, Lin H, Howell HB, Heath AC, Cohen LS (Apr 2008) Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine., The Journal of clinical psychiatry, 69 (4), 659-65
 - Yonkers KA, O'Brien PM, Eriksson E (Apr 2008) Premenstrual syndrome., Lancet, 371 (9619), 1200-10
 - Kessler RC, Gruber M, Hettema JM, Hwang I, Sampson N, Yonkers KA (Mar 2008) Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up., Psychological medicine, 38 (3), 365-74
 - Yonkers KA (Oct 2007) The treatment of women suffering from depression who are either pregnant or breastfeeding., The American journal of psychiatry, 164 (10), 1457-9
 - Borenstein JE, Dean BB, Leifke E, Korner P, Yonkers KA (Oct 2007) Differences in symptom scores and health outcomes in premenstrual syndrome., Journal of women's health (2002), 16 (8), 1139-44
 - Rogal SS, Poschman K, Belanger K, Howell HB, Smith MV, Medina J, Yonkers KA (Sep 2007) Effects of posttraumatic stress disorder on pregnancy outcomes., Journal of affective disorders, 102 (1-3), 137-43
 - Borenstein, JE, Dean, BB, Yonkers, KA, Endicott, J (2007) Using the Daily Record of Severity of Problems as a Screening Instrument for Premenstrual Syndrome, Obstetrics and Gynecology, 109 (5), 1068-1075
- Halbreich, U, Backstrom, T, Eriksson, E, O'Brien, S, Calil, H, Ceskova, E, Dennerstein, L, Douki, S, Freeman, E, Genazzani, A, Heuser, I, Kadri, N, Rapkin, A, Steiner, M, Wittchen, HU, Yonkers, KA (2007) Clinical Diagnostic Criteria of Premenstrual Syndrome and Guidelines for their Quantification for Research Studies, Gynecological Endocrinology, 23 (3), 123-130
- Dean, BB, Borenstein, JE, Knight, K, Yonkers, KA (2006) Evaluating the Criteria Used for the Identification of PMS, Journal of Women's Health, 15 (5), 546-555
- Yonkers, KA, Holthausen, GA, Poschman, KP, Howell, HB (2006) Symptom Onset Treatment for Women with Premenstrual Dysphoric Disorder, Journal of Clinical Psychopharmacology, 26, 198-202
- Smith, MV, Poschman, KP, Allen, AA, Cavaleri, MA, Howell, HB, Yonkers, KA (2006) Symptom Profiles of PTSD in Pregnancy, American Journal of Psychiatry, 163, 881-884
- Pearlstein, T, Yonkers, KA, Fayyad, R, Gillespie, JA (2005) Pretreatment Pattern of Symptom Expression in Premenstrual Dysphoric Disorder, Journal of Affective Disorders, 85, 275-282
- Bruce, SE, Yonkers, KA, Otto, MW, Eisen, JL, Weisberg, RB, Pagano, M, Shea, MT, Keller, MB (2005) Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: a 12-Year Prospective Study, American Journal of Pyschiatry, 162 (6), 1179-1187
- Pearlstein, T, Bachmann, GA, Zacur, HA, Yonkers, KA (2005) Treatment of Premenstrual Dysphoric Disorder with a New Drospirenone-Containing Oral Contraceptive Formulation, Contraception, 73, 414-421
- Yonkers KA, Pearlstein T, Fayyad R, Gillespie JA (2005) Luteal phase treatment of premenstrual dysphoric disorder (PMDD) improves symptoms that continue into postmenstrual phase, Journal of Affective Disorders, 85 (3), 317-321
- Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A (2005) Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder., Obstetrics & Gynecology, 106, 492-501
- Smith M, Cavaleri MA, Howell HB, Poschman K, Rosenheck RA, Yonkers KA, Screening for and detection of depression, panic disorder and PTSD in public sector obstetrical clinics, Psychiatric Services, 55, 407-414, 2004
- Yonkers KA, Wisner K, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L, Management of bipolar disorder during pregnancy and the postpartum period, American Journal of Psychiatry, 161(4), 608-620, 2004
- Borenstein JE, Dean B, Endicott J, Wong J, Brown C, Dickerson V, Yonkers KA, The Health and economic impact of premenstrual syndrome, The Journal of Reproductive Medicine, 48(7), 515-524., 2003
Profile DetailsIndividual Expertise profile of Kimberly A. Yonkers, Copyright Kimberly A. Yonkers. © COS Expertise TM, 2009, ProQuest LLC All rights reserved. |